LanzaTech (US:LNZA) Globenewswire·2025-04-15 20:15Core Insights - LanzaTech Global, Inc. reported a significant decline in revenue for both the fourth quarter and full year of 2024 compared to 2023, primarily due to project completion and timing delays in large biorefining projects [3][4][5] Financial Results - Fourth-quarter 2024 revenue was $12.0 million, down from $20.5 million in the same quarter of 2023, while full-year revenue decreased to $49.6 million from $62.6 million [3][4][5] - Cost of revenue for the fourth quarter was $5.6 million, compared to $12.0 million in Q4 2023, leading to a gross profit of $6.5 million for Q4 2024 [7] - Operating expenses increased to $33.5 million in Q4 2024 from $27.1 million in Q4 2023, driven by project-related expenses [8] - The net loss for Q4 2024 was $27.0 million, compared to a net loss of $18.7 million in Q4 2023, with full-year net loss at $137.7 million versus $134.1 million in 2023 [9][10] Adjusted EBITDA - Adjusted EBITDA losses for Q4 2024 were $21.2 million, compared to $19.6 million in Q4 2023, with full-year adjusted EBITDA losses of $88.2 million versus $80.1 million in 2023 [10][29] Revenue Breakdown - Joint Development Agreement (JDA) and Contract Research revenue for Q4 2024 was $1.7 million, down from $4.2 million in Q4 2023, while CarbonSmart revenue increased to $3.9 million from $2.1 million in the same period [13] Balance Sheet and Liquidity - As of December 31, 2024, LanzaTech had $58.1 million in total cash and investments, a decrease from $89.1 million at the end of Q3 2024 [11] - Total assets decreased to $174.7 million from $241.6 million in 2023, with total liabilities increasing to $161.2 million from $127.2 million [21][22] Strategic Focus - The company is shifting its operational focus from research and development to global deployment, aiming to enhance its cost structure and liquidity through capital raising and strategic partnerships [5][8]